These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 16166229)

  • 1. Dopamine and transforming growth factor-beta1: an odd couple in growth inhibition of the lactotrophs.
    Ben-Jonathan N
    Endocrinology; 2005 Oct; 146(10):4177-8. PubMed ID: 16166229
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of phospholipase D activity in transforming growth factor-beta-induced cell growth inhibition.
    Zhou BH; Chen JS; Chai MQ; Zhao S; Liang J; Chen HH; Song JG
    Cell Res; 2000 Jun; 10(2):139-49. PubMed ID: 10896175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ethanol and transforming growth factor beta (TGF beta) on neuronal proliferation and nCAM expression.
    Miller MW; Luo J
    Alcohol Clin Exp Res; 2002 Aug; 26(8):1281-5. PubMed ID: 12198406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth regulation by transforming growth factor-beta.
    Arrick BA; Derynck R
    Cancer Treat Res; 1992; 63():255-64. PubMed ID: 1363360
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-beta-dependent and -independent mechanisms.
    Miao WM; Seng WL; Duquette M; Lawler P; Laus C; Lawler J
    Cancer Res; 2001 Nov; 61(21):7830-9. PubMed ID: 11691800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine release of TGF-beta by portal fibroblasts regulates cell growth.
    Wells RG; Kruglov E; Dranoff JA
    FEBS Lett; 2004 Feb; 559(1-3):107-10. PubMed ID: 14960316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of TGB-beta1 on schwann cells in peripheral nerve regeneration].
    Pei YY; Zeng ZC
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):332-4. PubMed ID: 16136973
    [No Abstract]   [Full Text] [Related]  

  • 8. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS; Lee HS; Kim TY; Im YH; Park JW; Kim NK; Bang YJ
    Biochem Biophys Res Commun; 2002 Mar; 292(2):383-9. PubMed ID: 11906173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of proliferation, motility, and contractivity of cultured human endometrial stromal cells by transforming growth factor-beta isoforms.
    Nasu K; Nishida M; Matsumoto H; Bing S; Inoue C; Kawano Y; Miyakawa I
    Fertil Steril; 2005 Oct; 84 Suppl 2():1114-23. PubMed ID: 16210002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in TGF-beta receptors of rat hepatocytes during primary culture and liver regeneration: increased expression of TGF-beta receptors associated with increased sensitivity to TGF-beta-mediated growth inhibition.
    Nishikawa Y; Wang M; Carr BI
    J Cell Physiol; 1998 Sep; 176(3):612-23. PubMed ID: 9699514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Negative regulators of cell growth].
    Liu Y; Tong TJ
    Sheng Li Ke Xue Jin Zhan; 1992 Jan; 23(1):26-9. PubMed ID: 1384121
    [No Abstract]   [Full Text] [Related]  

  • 12. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice.
    Oe S; Lemmer ER; Conner EA; Factor VM; Levéen P; Larsson J; Karlsson S; Thorgeirsson SS
    Hepatology; 2004 Nov; 40(5):1098-105. PubMed ID: 15389868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro assays for measuring TGF-beta growth stimulation and inhibition.
    Edens M; Leof EB
    Methods Mol Biol; 2000; 142():1-11. PubMed ID: 10806609
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model.
    Tuxhorn JA; McAlhany SJ; Yang F; Dang TD; Rowley DR
    Cancer Res; 2002 Nov; 62(21):6021-5. PubMed ID: 12414622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis.
    Fynan TM; Reiss M
    Crit Rev Oncog; 1993; 4(5):493-540. PubMed ID: 8241322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
    Song K; Cornelius SC; Danielpour D
    Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta1 and renal cell cancer: cell growth, mRNA expression and protein production of cytokines.
    Shimabukuro T; Ohmoto Y; Naito K
    J Urol; 2003 May; 169(5):1865-9. PubMed ID: 12686863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)(2)D(3).
    Chen A; Davis BH; Sitrin MD; Brasitus TA; Bissonnette M
    Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G864-74. PubMed ID: 12223346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells.
    Lee BI; Park SH; Kim JW; Sausville EA; Kim HT; Nakanishi O; Trepel JB; Kim SJ
    Cancer Res; 2001 Feb; 61(3):931-4. PubMed ID: 11221885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-mesenchymal interactions and lung branching morphogenesis. Role of polyamines and transforming growth factor beta1.
    Stabellini G; Locci P; Calvitti M; Evangelisti R; Marinucci L; Bodo M; Caruso A; Canaider S; Carinci P
    Eur J Histochem; 2001; 45(2):151-62. PubMed ID: 11512636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.